Abstract:Asian American (24 million people) and Native Hawaiian and other Pacific Islander (1.7 million people) individuals represent 8% of the US population. 1 Cancer is the leading cause of death among many Asian American groups (Chinese, Filipino, Vietnamese, and Korean) and is the second leading cause of death among Native Hawaiian, Indian, and Japanese American people. 1 A growing body of research has focused on cancer among these very diverse groups, elucidating their unique and dynamic cancer risk factors, epidemiology, and access to care. 2 ,3 Zhu et al 4 evaluated cancer-specific mortality (CSM) rates for Asian American, Native Hawaiian, and other Pacific Islander individuals from 1999 to 2020 using the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research database. They found that for these groups in aggregate, CSM rates decreased over the past 2 decades and that decreases were greater among men than among women. The CSM rates among women increased for cancers of the uterus and the brain and central nervous system but decreased for other cancer sites. Upon analysis by age, women aged 65 to 74 years experienced the greatest increase in mortality from uterine cancer. Among men, CSM rates decreased overall, with the greatest decreases in cancers of the stomach and lung. Decreases in CSM were greatest in cancers of the liver and lung among men aged 35 to 44 years; however, colorectal cancer mortality increased among men aged 45 to 54 years, and after a decrease from 2002 to 2012, prostate cancer increased among men aged 64 to 74 years (from 2012 to 2020). The authors found increased mortality for pancreatic cancer in the Midwest and for uterine cancer and liver cancer across all US census regions. The study by Zhu et al 4 highlights the need to further study and address the cancer burden among these rapidly growing populations. 1 Their work is nationally representative and may inform cancer policy. Their findings illustrate how cancer mortality has changed over time, reflecting changes in risk factors, screening rates, and timely and equitable access to quality cancer care. 2 -4 The study is limited by the aggregation of diverse Asian American and Pacific Islander groups, who exhibit some of the widest disparities in social determinants of health across census groups, 1 -3 a limitation inherent in the dataset that masks heterogeneity in cancer mortality. 1 -3 Heterogeneity in cancer mortality is notable. The age-adjusted mortality rate for all cancer subsites is 142 per 100 000 for Native Hawaiian and Pacific Islander patients, 91 per 100 000 for Asian American patients, and 153 per 100 000 for White patients. 1 For uterine cancer, the age-adjusted mortality rate is 16 per 100 000 for Native Hawaiian and Pacific Islander patients compared with 5 per 100 000 for White patients and 3 per 100 000 for Asian American patients. 1 For breast cancer, 5-year relative survival is 94% for Japanese American and 93% for White and Chinese patients compared with 72% for Tongan, 73% for Chamorro and Guamanian, and 74% for Samoan patients. 1 For cancers of the lung and bronchus, 5-year relative survival is 37% for Thai, 36% for Chinese, 35% for Pakistani, and 29% for Indian patients compared with 25% for White, 18% for Samoan, 15% for Tongan, and 11% for Laotian patients. 1 Such heterogeneity in mortality may reflect differences across the continuum of disease leading up to mortality estimates. 2 Considering the current study and in the context of such heterogeneity, what are the next steps? First, further disaggregated research is needed to examine the drivers of these temporal changes. Although CSM has decreased overall for Asian American, Native Hawaiian, and Pacific Islander patients, decreases in lung CSM may be driven by relatively better survival among Chinese and Indian patients (and perhaps to a lesser extent by the smaller Thai and Pakistani populations) but may not reflect the substantially lower survival among several Pacific Islander and Southeast Asian (eg, Laotian) groups. 1 Increases in uterine CSM may reflect the burden of disease among Native Hawaiian and Pacific Islander individuals, among whom focused studies and interventions are needed. 1 ,3 Further research could explore how cancer risk compares between immigrants and people in their countries of origin and how cancer risk changes across generations of immigrants. 5 Parallels between immigrants and their countries of origin may inform targeted diagnostics, as exemplified by the high rate of gastric cancer among Korean American individuals reflecting epidemiology in Korea. 1 ,5 Such work may also elucidate how risk changes in th -Abstract Truncated-

Cancer mortality in Hispanic ethnic groups

Cancer Mortality among Hispanic groups in the US, by birthplace (2003-2017)

Unpacking Hispanic ethnicity—cancer mortality differentials among Hispanic subgroups in the United States, 2004–2014

Cancer Statistics for Hispanics/Latinos, 2018

Cancer statistics for hispanics/latinos, 2015

Cancer statistics for the US Hispanic/Latino population, 2021

Cancer statistics for hispanics/latinos, 2012

Abstract PR015: Cancer Incidence in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) – The Onco-SOL Ancillary Study

Cancer‐related risk factors and preventive measures in US Hispanics/Latinos

Cancer facts and figures for Hispanics/Latinos 2006–2008

Cancer Mortality Disparities among Asian American and Native Hawaiian/Pacific Islander Populations in California

Gastrointestinal cancer trends in the Hispanic population: A SEER database population study (2000-2019).

Abstract A085: Exploring disparities in cancer disease cohort prevalence: Unpacking Hispanic heterogeneity within All of Us

Unveiling Disparities: Analyzing Hispanic Inclusion in Liver Cancer Research Databases in the United States

Lung Cancer Incidence by Detailed Race–Ethnicity

Dissecting racial/ethnic disparities in non-small cell lung cancer staging at diagnosis: Intra-ethnic and geographic differences.

Ethnic Differences in Survival Among Lung Cancer Patients: A Systematic Review

Prevalence of modifiable risk factors of Hispanic adult patients admitted with gastric cancer in the US.

Breast cancer disparities among Hispanics in the US: Insights into healthcare access.

Disaggregated Cancer Research and Intervention for Asian American and Pacific Islander People